Topic
DETROIT (November 14, 2024) – TrialAssure®, a leader in AI Enabled, Human Driven™ software solutions for the pharmaceutical industry, announced today that it earned local recognition as a…
Recently, TrialAssure attended the 5th Annual Pharma AI Summit in London. This event brought together industry leaders and innovators to discuss the transformative potential of AI in the…
Artificial intelligence (AI) in healthcare was a hot topic of conversation at the recent MichBio Medical Device Summit in Ann Arbor last week. The conversation centered on AI’s…
SAN DIEGO – TrialAssure, a leading provider of pharmaceutical technology advancing clinical trial disclosure, data sharing, and transparency, announced today the release of TrialAssure LINK® AI 2.0. This new…
CANTON, Mich. (April 22, 2024) — TrialAssure today announced it has joined NVIDIA Inception, a program that nurtures companies revolutionizing industries with technological advancements. TrialAssure is a leader…
CANTON, Mich. (March 14, 2024) – TrialAssure, a leading pharmaceutical technology provider advancing clinical trial disclosure, data sharing, and transparency, announced that its flagship product TrialAssure ANONYMIZE® 3.0…
CANTON, Mich. (August 3, 2023) – TrialAssure, a leading software-as-a-service (SaaS) provider advancing clinical trial disclosure, data sharing, and transparency, announced today that it is collaborating with MMS,…
DETROIT (June 9, 2023) – TRUSANOTM, a state-of-the-art data and document anonymization, redaction, and masking software, is now available globally. Developed by TrialAssure – an award-winning leader in…
Artificial intelligence (AI) in the pharmaceutical industry is growing as “the global artificial intelligence market size was valued at USD 136.55 billion in 2022 and is projected to…
Canton, Mich. (November 7, 2019) – TrialAssure® – a leading, global software company advancing clinical trial transparency tools – announced today the limited release of ANONYMIZE R, a…
